Key result
Neuroleptic malignant syndrome developed in a patient with Wilson's disease.
Key points are not available for this paper at this time.
Alerts clinicians to possible NMS in Wilson's disease; leaves open whether neuroleptics confer unique risk.
No takes yet. Share an insight, caveat, or question.
Kontaxakis et al. (1988) studied this question. Neuroleptic malignant syndrome developed in a patient with Wilson's disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: